Norihisa Ohtake

Secretome-Based Identification of TFPI2, A Novel Serum Biomarker for Detection of Ovarian Clear Cell Adenocarcinoma

Noriaki Arakawa, Etsuko Miyagi, Ayako Nomura et al. · Journal of Proteome Research · 2013 · 79 citations

Oncology, Endocrine-related Cancer, Secretome-based Identification +13

Clinical Significance of Tissue Factor Pathway Inhibitor 2, a Serum Biomarker Candidate for Ovarian Clear Cell Carcinoma

Noriaki Arakawa, Hiroshi Kobayashi, Naohiro Yonemoto et al. · PLoS ONE · 2016 · 38 citations · Full text

Vaccine-induced humoral response against SARS-CoV-2 dramatically declined but cellular immunity possibly remained at 6 months post BNT162b2 vaccination

Hideaki Kato, Kei Miyakawa, Norihisa Ohtake et al. · Vaccine · 2022 · 37 citations · Full text

Rapid quantitative screening assay for SARS-CoV-2 neutralizing antibodies using HiBiT-tagged virus-like particles

Kei Miyakawa, Sundararaj Stanleyraj Jeremiah, Norihisa Ohtake et al. · Journal of Molecular Cell Biology · 2020 · 34 citations · Full text

Diagnostic Virology, Neutralization Activity, Viral Diagnostics +11

Tissue factor pathway inhibitor‑2 is specifically expressed in ovarian clear cell carcinoma tissues in the nucleus, cytoplasm and extracellular matrix

Yukihide Ota, Shiro Koizume, Yoshiyasu Nakamura et al. · Oncology Reports · 2021 · 25 citations · Full text

Occc Cell Lines, Medicine, Other Cell Lines +12